Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
Madeline R Hale, Rebecca Langhough, Lianlian Du, Bruce P Hermann, Carol A Van Hulle, Margherita Carboni, Gwendlyn Kollmorgen, Kristin E Basche, Davide Bruno, Leah Sanson-Miles, Erin M Jonaitis, Nathaniel A Chin, Ozioma C Okonkwo, Barbara B Bendlin, Cynthia M Carlsson, Henrik Zetterberg, Kaj Blennow, Tobey J Betthauser, Sterling C Johnson, Kimberly D Mueller
Neuropsychological measures sensitive to decline in the preclinical phase of Alzheimer's disease are needed. We previously demonstrated that higher amyloid-beta (Aβ) assessed by positron emission tomography in adults without cognitive impairment was associated with recall of fewer proper names in Logical Memory story recall. The current study investigated the association between proper names and cerebrospinal fluid biomarkers (Aβ42/40 , phosphorylated tau181 [pTau181 ], neurofilament light) in 223 participants from the Wisconsin Registry for Alzheimer's Prevention. We assessed associations between biomarkers and delayed Logical Memory total score and proper names using binary logistic regressions. Sensitivity analyses used multinomial logistic regression and stratified biomarker groups. Lower Logical Memory total score and proper names scores from the most recent visit were associated with biomarker positivity. Relatedly, there was a 27% decreased risk of being classified Aβ42/40 +/pTau181 + for each additional proper name recalled. A linear mixed effects model found that longitudinal change in proper names recall was predicted by biomarker status. These results demonstrate a novel relationship between proper names and Alzheimer's disease-cerebrospinal fluid pathology.
Full text links
We have located links that may give you full text access.